NICARDIPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicardipine, and when can generic versions of Nicardipine launch?
Nicardipine is a drug marketed by Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Mylan, Senores Pharms, Skg Pharma, Am Regent, Eugia Pharma, Hikma Intl Pharms, Micro Labs, Navinta Llc, Rk Pharma, Sun Pharm, West-ward Pharms Int, Wockhardt, and Inforlife. and is included in nineteen NDAs.
The generic ingredient in NICARDIPINE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicardipine
A generic version of NICARDIPINE was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NICARDIPINE?
- What are the global sales for NICARDIPINE?
- What is Average Wholesale Price for NICARDIPINE?
Summary for NICARDIPINE
US Patents: | 0 |
Applicants: | 17 |
NDAs: | 19 |
Drug Prices: | Drug price information for NICARDIPINE |
DailyMed Link: | NICARDIPINE at DailyMed |